Glibenclamide (Amglidia)

Status:
Red
Decision Date:
December 2019
 

Comments

RED: oral suspension for the treatment of neonatal diabetes mellitus, for use in newborns, infants and children

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app